A database of FDA approved therapeutic peptides and proteins
ID1331 | ThPPIDTh1047 | NameAlpha-1-proteinase inhibitor | Peptide SequenceEDPQGDAAQKTDTSHHDQDH Full view | Length255 | Functional ClassificationIIa | DiseaseMetabolic/Geneti/Respiratory | BrandAralast | CompanyBaxter | Physical AppearanceLyophilized powder | Route of AdministartionIntravenous infusion | CategorySerine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors | TargetNeutrophil elastase |
ID1332 | ThPPIDTh1047 | NameAlpha-1-proteinase inhibitor | Peptide SequenceEDPQGDAAQKTDTSHHDQDH Full view | Length255 | Functional ClassificationIIa | DiseaseMetabolic/Geneti/Respiratory | BrandProlastin | CompanyTalecris Biotherapeutics C formerly Bayer | Physical AppearanceLyophilized powder | Route of AdministartionIntravenous infusion | CategorySerine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors | TargetNeutrophil elastase |
ID1706 | ThPPIDTh1169 | NameBeractant | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseRespiratory | BrandSurvanta | CompanyAbb Vie Inc. | Physical AppearanceSuspension | Route of AdministartionEndotracheal | CategoryNA | TargetNA |
ID1707 | ThPPIDTh1169 | NameBeractant | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseRespiratory Disorder | BrandSurvanta | CompanyAbbvie Corporation | Physical AppearanceSuspension | Route of AdministartionIntratracheal | CategoryNA | TargetNA |
ID1810 | ThPPIDTh1201 | NamePoractant alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseRespiratory Disorder | BrandCurosurf | CompanyChiesi USA, Inc | Physical AppearanceSuspension | Route of AdministartionEndotracheal | CategoryPulmonary Surfactants | Target |
ID1819 | ThPPIDTh1210 | NameMepolizumab | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseRespiratory Disorder | BrandNucala | CompanyGlaxosmithkline Inc | Physical AppearanceLyophilized Powder | Route of AdministartionSubcutaneous | CategoryAntineoplastic and Immunomodulating Agents, Immunosuppressive Agents, Interleukin Inhibitors | TargetInterleukin-5 |